Filing Details

Accession Number:
0001093557-24-000010
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-17 18:47:16
Reporting Period:
2024-01-16
Accepted Time:
2024-01-17 18:47:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1093557 Dexcom Inc DXCM Surgical & Medical Instruments & Apparatus (3841) 330857544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1191307 R Steven Altman 6340 Sequence Drive
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-01-16 460 $121.97 54,240 No 4 S Indirect by Trust
Common Stock Disposition 2024-01-16 1,108 $123.24 53,132 No 4 S Indirect by Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect by Trust
No 4 S Indirect by Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,885 Direct
Footnotes
  1. On May 30, 2023, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan.
  2. This transaction was executed in multiple trades at prices ranging from $121.44 to $122.24 per share. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  3. Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee.
  4. This transaction was executed in multiple trades at prices ranging from $122.86 to $123.65 per share. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.